AGHeadlines October 2024
- Hannah Hunt
- Oct 29, 2024
- 2 min read
After listening to your feedback requesting more frequent updates, we would like to welcome you to the inaugural edition of AGHeadlines: your new bulletin for data, news, and events. We will be bringing you updates every 3 months on AmniSure, PartoSure, Dilapan-S, 4DryField PH, Lumella, Neotech, and DandleLION to help you achieve the best possible outcomes by staying informed of the latest developments and resources.
What’s in this edition?
New evidence and data
Upcoming events
Meet your account manager
We’re hiring!
NEW EVIDENCE AND DATA
DILAPAN-S – IND-HOME trial completion
RCT comparing DILAPAN-S and dinoprostone vaginal insert in an outpatient setting for nulliparous women who had agreed to elective IOL at 39 weeks
Both DILAPAN-S and PROPESS, when used for 24-hour insertions, achieved comparably high vaginal delivery rates, with 75% of participants successfully delivering vaginally, with no significant adverse maternal or neonatal outcomes
Read the full paper here
4DryField PH – Two new studies to be presented at ESGE on October 29th
The ASPIRE study: A prospective, multicenter, randomised trial on impact of adhesion prophylaxis with 4DryField during endometriosis resection on pain, fertility, and quality of life
First results of a randomised controlled trial on intrauterine adhesion prevention with 4DryField® PH
UPCOMING EVENTS
AGHealth will be present at: BIARGS 15-16th November & MMF Scotland 26th November
Webinars:
MEET YOUR ACCOUNT MANAGER
Contact Shelley here
Contact Mike here
Contact Junaid here
WE'RE HIRING!
We’re looking for someone to join our incredible team as a medical sales representative for the South of England. Find more information on our website.
